7
landing page
Frontotemporal Dementia
Frontotemporal Dementia
Frontotemporal dementia (FTD) describes brain conditions characterized by p
rogressive degeneration of the brain’s frontal and temporal lobes., About the Kissick Family Foundation FTD Grant Program
The Kissick Family Foundation partnered with MI Philanthropy’s Science and Health team in 2022 to analyze and understand the state of the FTD research ecosystem and identify where phi,
, Please
+ Read More
report
Request for Proposals: Ann Theodore Foundation Breakthrough Sarcoidosis Initiative
Third Round of Funding Available for Sarcoidosis Research
The Ann Theodore Foundation, in partners
hip with MI Philanthropy, launched The Ann Theodore Foundation Breakthrough Sarcoidosis Initiative (ATF-BSI) in 2021, a grant program focused on
+ Read More
report
Childhood Brain Cancer: A Giving Smarter Guide
Pediatric brain cancer accounts for 16 percent of all new childhood cancer diagnoses, making it one
of the most common cancer diagnoses in children and adolescents. It is also the leading cause of cancer death within this age group.
+ Read More
report
Corporate Philanthropy: Emerging Strategies for Lasting Impact
Corporate philanthropy is in transition. External trends and heightened stakeholder expectations ha
ve placed new pressures on the corporate sector.
+ Read More
report
Request for Proposals: Kissick Family Foundation Frontotemporal Dementia Grant Program
The Kissick Family Foundation, with guidance from MI Philanthropy’s Science and Health team, is rel
easing its first Request for Proposals (RFP) to fund research that accelerates basic and fundamental discoveries for sporadic FTD.
+ Read More
report
Frontotemporal Dementia: A Giving Smarter Guide
Frontotemporal dementia (FTD) refers to a family of neurodegenerative conditions that cause changes
in behavior, mood, executive function, language, memory, and motor function.
+ Read More
article
Multimillion-Dollar Scientific Grant Program Releases Third Cycle of Funding to Increase Foundational Understanding of Sarcoidosis
WASHINGTON, DC (September 20, 2023) — The Ann Theodore Foundation Breakthrough Sarcoidosis
Initiative (ATF-BSI), in partnership with the Mil
+ Read More